Synchronous hepatocellular carcinoma and cholangiocellular carcinoma on 18F-FDG PET/CT 18F-FDG PET/BT’de senkron hepatosellüler karsinoma ve kolanjiosellüler karsinoma


ERDOĞAN E. B. , TÜRK H. M. , TEKÇE E. , AYDIN M.

Molecular Imaging and Radionuclide Therapy, vol.27, no.3, pp.136-137, 2018 (Refereed Journals of Other Institutions) identifier

  • Publication Type: Article / Article
  • Volume: 27 Issue: 3
  • Publication Date: 2018
  • Doi Number: 10.4274/mirt.93723pmid:30317851
  • Title of Journal : Molecular Imaging and Radionuclide Therapy
  • Page Numbers: pp.136-137

Abstract

© 2018 by Turkish Society of Nuclear Medicine Molecular Imaging and Radionuclide Therapy published by Galenos Yayınevi.A 43-year-old male patient presented with a mass lesion on the right liver lobe, segment 5, in radiological imaging and elevated alpha-fetoprotein levels (323 ng/mL) compatible with hepatocellular carcinoma (HCC). Positron emission tomography/ computed tomography (PET/CT) images showed background level18F-FDG uptake in the mass lesion. In addition, a secondary focus of increased18F-FDG uptake was detected on the left liver lobe, segment 2, approximately 1,5 cm in diameter. Histopathological examination revealed HCC in the larger mass lesion with a lower18F-FDG uptake, and cholangiocellular carcinoma in the smaller mass lesion with a higher18F-FDG uptake. To our knowledge, this is the first case report of two histopathologically different primary malignant liver tumors in two distinct segments of the liver detected by PET/CT.